The Director, Clinical Quality Assurance is primarily responsible for establishing and leading the Clinical QA function and providing independent oversight of Good Clinical Practices (GCP) activities to ensure compliance with FDA, EMA, ICH, and other applicable global and national regulatory requirements across Cellectis’ clinical programs. This role provides strategic and operational quality leadership in alignment with other departments and company goals. They develop and implement a comprehensive Clinical Quality Assurance framework that safeguards patient safety, data integrity, and regulatory compliance throughout the clinical development lifecycle. The Director, Clinical Quality Assurance, will manage activities and projects based on short-term and long-term company goals. This position is also part of the Global Cellectis Quality Leadership team actively contributing to the overall global Quality strategy and initiatives.
Position Responsibilities
Defines and executes the Clinical QA strategy throughout the development trajectory including early-phase and late stage clinical development
Oversees GCP compliance for all clinical activities, including monitoring, data management, and pharmacovigilance
Develop and implement inspection readiness plans and procedures ensuring that clinical studies and related activities are ready for Health Authority inspections
Direct risk-based quality planning and continuous improvement initiatives across clinical programs
Manage vendor qualifications, audits, and corrective/preventive actions (CAPAs)
Collaborate cross-functionally to integrate quality principles into clinical development and regulatory deliverables
Provide training and guidance to cross-functional teams on GCP regulations, Quality Assurance procedures, and audit protocols
Develops quality strategies and priorities for short- and long-term objectives for the QA organization.
In collaboration with internal stakeholders, ensure risk-based quality management is applied as appropriate to specific studies
Facilitate review of potential Serious Breach and Urgent Safety Measure assessments arising from clinical program
Plan, coordinate, review, and approve clinical audits using risk-informed strategy to ensure compliance in clinical studies and pharmacovigilance operations
Implement and run internal GCP audit and training programs
Serve as a subject matter expert on GCP quality assurance matters
Develop KPIs to track and trend key Quality Indicators and ensures that any adverse trends or patterns are noted and are promptly addressed
Travel up to 10% of the time
Such other responsibilities and duties as the Company may from time-to-time assign
Education and Experience
Bachelor’s or master’s degree in science preferably in a Life Science, with at least twelve (12) years of relevant GCP, PV, and QA experience in a biopharmaceutical company. 8+ years of direct supervisory experience.
Extensive clinical trial experience in biological therapies and in oncology, ideally in CAR-T therapies and hemato-oncology.
Experience supporting IND, CTA, and BLA/MAA or other regulatory submissions.
Technical Skills / Core Competencies
Demonstrated ability to identify critical program risks and develop plans, strategic or tactical, to mitigate risks and costs. Knowledge and understanding of regulations regarding cell/gene therapies including but not limited to ICH guideline, GCP, and GMP as defined by the US Food and Drug Administration and European Medicines Agency.
Comprehensive knowledge of cell and gene therapy, GxPs, and the theories and general principles behind them.
Comprehensive knowledge of compliance with GCP worldwide regulations. Strong project management skills.
Demonstrated ability to lead, motivate, and influence a strategic direction. Ability to effectively leverage and develop diverse perspectives and ideas from matrix teams.
Ability to independently lead initiatives, assess complex challenges, and implement practical solutions.
Strong written and verbal communication skills. Bilingual in French and English preferred.
Ability to set and manage priorities and schedule activities accordingly. Strong analytical and problem-solving skills.
Demonstrated interpersonal skills to work effectively with subordinates, peers, managers, and cross-functional teams.
Excellent organizational skills with attention to detail and deadlines.
Strong team orientation including the ability to coach and mentor.
Anticipated Compensation Range: $190,000 - $234,0000
Skills Required
- Bachelor's or master's degree in science, preferably in Life Science
- At least twelve years of relevant GCP, PV, and QA experience in biopharmaceuticals
- 8+ years of direct supervisory experience
- Extensive clinical trial experience in biological therapies and oncology, ideally CAR-T therapies
- Experience supporting IND, CTA, and BLA/MAA submissions
What We Do
Cellectis is a global, clinical-stage biopharmaceutical company. As pioneers and innovators in our field, we are driven by a single mission: to develop breakthrough treatments for patients with unmet medical needs. With 26 years of expertise, we operate a best-in-class genome editing platform focused on immuno-oncology and gene therapy. By leveraging our proprietary gene-editing technologies, we engineer allogeneic CAR-T cells designed to recognize and eliminate cancer cells. Currently, our two lead clinical programs are evaluating therapies for B-cell acute lymphoblastic leukemia (B-ALL) and non-Hodgkin lymphoma (NHL). As a fully integrated leader in genome editing and allogeneic CAR-T cell research, we maintain complete end-to-end control over our manufacturing process. This vertical integration ensures quality across the board: • Paris, France: Production of starting materials • Raleigh, NC (USA): Manufacturing of the finished CAR-T products We have established powerful collaborations with industry leaders, including AstraZeneca and Allogene Therapeutics, to accelerate the development of product candidates across oncology, immunology, and rare diseases. Cellectis headquarters are in Paris, France, with additional locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find out more about us, visit our website: www.cellectis.com. To learn more about our community guidelines, visit: http://www.cellectis.com/en/social-media-guidelines/ Follow our other social media account on X. TALEN® is a registered trademark owned by the Cellectis Group.









